Sign In
Buy PEG
$78.78
+0.190 (+0.242%)
At Close: Jun 11, 2026
PSEG ANNOUNCES THIRD QUARTER 2025 RESULTS
07:30am, Monday, 03'rd Nov 2025
$1.24 PER SHARE NET INCOME $1.13 PER SHARE NON-GAAP OPERATING EARNINGS NEWARK, N.J., Nov. 3, 2025 /PRNewswire/ -- Public Service Enterprise Group (NYSE: PEG) reported the following results for the th
OGE Energy (NYSE:OGE) vs. Public Service Enterprise Group (NYSE:PEG) Critical Survey
01:47am, Monday, 03'rd Nov 2025
OGE Energy (NYSE: OGE - Get Free Report) and Public Service Enterprise Group (NYSE: PEG - Get Free Report) are both utilities companies, but which is the better investment? We will compare the two com
D.A. Davidson & CO. Reduces Stake in Public Service Enterprise Group Incorporated $PEG
03:58am, Thursday, 30'th Oct 2025
D.A. Davidson and CO. lessened its position in shares of Public Service Enterprise Group Incorporated (NYSE: PEG) by 2.4% in the second quarter, according to the company in its most recent Form 13F fi
PSEG (PEG) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:16am, Wednesday, 29'th Oct 2025
Evaluate the expected performance of PSEG (PEG) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics fo
With Winter Heating Season Nearing, PSEG Long Island Hosts Community Events to Help Customers Struggling with Bills
01:45pm, Monday, 27'th Oct 2025
Support programs and deferred payment plans are available to eligible customers UNIONDALE, N.Y. , Oct. 27, 2025 /PRNewswire/ -- As winter heating season approaches, PSEG Long Island is holding three
PSEG (PEG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:00am, Monday, 27'th Oct 2025
PSEG (PEG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Low-PEG GARP Stocks That Perfectly Balance Growth and Value
04:00pm, Thursday, 23'rd Oct 2025
Carnival, Micron, Synchrony and Ericsson shine as low-PEG GARP picks, blending growth and value strategies.
All You Need to Know About PSEG (PEG) Rating Upgrade to Buy
01:01pm, Thursday, 23'rd Oct 2025
PSEG (PEG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PSEG To Announce Third Quarter 2025 Financial Results On November 3
07:30am, Tuesday, 14'th Oct 2025
NEWARK, N.J., Oct. 14, 2025 /PRNewswire/ -- Public Service Enterprise Group Incorporated (PSEG) will host its third quarter 2025 earnings call at 11:00 a.m.
Bet on 5 Top-Ranked Stocks With Rising P/E
10:11am, Friday, 03'rd Oct 2025
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Public Service Enterprise Group, Genpact, The Progressive, Exelon and Butterfly Network.
Top 4 PEG-Rated GARP Picks Blending Value With Growth Potential
10:56am, Monday, 29'th Sep 2025
Micron, StoneCo, PagSeguro and Daktronics emerge as our PEG-rated GARP picks, blending discounted value with strong growth prospects.
PSEG Long Island to Continue Serving Long Island and the Rockaways for the Next Five Years
12:54pm, Thursday, 25'th Sep 2025
LIPA Board of Trustees awards PSEG Long Island extension of existing contract for five years continuing the successful partnership for the last 12 years. NEWARK, N.J.
After Plunging 8.9% in 4 Weeks, Here's Why the Trend Might Reverse for PSEG (PEG)
10:35am, Wednesday, 10'th Sep 2025
The heavy selling pressure might have exhausted for PSEG (PEG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in rev
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
11:55am, Thursday, 04'th Sep 2025
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis This company announcement r
